Leaflet TAUREDON 20mg 20mg / 0.5ml solution for injection
Indicated for: rheumatoid arthritis
Route of administration: injectable
Substance: sodium aurothiomalate (immunomodulator)
ATC: M01CB01 (Musculo-skeletal system | Specific antirheumatic agents | Gold preparations)
Avoid live vaccines during treatment if contraindicated.
This medicine may increase the risk of infections.
Use during breastfeeding only on medical advice.
Use during pregnancy only on medical advice.
Sodium aurothiomalate is a medication used in the treatment of rheumatoid arthritis, belonging to the class of gold salts. It works by reducing inflammation and slowing disease progression, although its exact mechanism of action is not fully understood.
The medication is administered via intramuscular injection, usually once a week at the start of treatment, with the dose adjusted based on the patient's response. Common side effects include skin rashes, itching, and stomatitis.
Sodium aurothiomalate is contraindicated in patients with severe renal or hepatic impairment, as well as those with hypersensitivity to gold salts. Its use during pregnancy and breastfeeding is also not recommended.
This medication is a therapeutic option for patients with rheumatoid arthritis who do not respond to other treatments, but it requires careful monitoring due to potential adverse effects.
General data about TAUREDON 20mg 20mg / 0.5ml
- Substance: sodium aurothiomalate
- Date of last drug list: 01-07-2013
- Commercial code: W07702001
- Concentration: 20mg / 0.5ml
- Pharmaceutical form: solution for injection
- Quantity: 5
- Product type: original
- Prescription restrictions: P-RF - Medicines prescription that is retained in the pharmacy (not renewable).
Concentrations available for sodium aurothiomalate
- 10mg/0.5ml
- 20mg/0.5ml
- 50mg/0.5ml